Oncology

Project awarded in 2019 under the H2020 program.

The goal of the EU-funded ISOLDA project is to develop novel vaccines against viral diseases for older age by promoting virus-specific T cell responses targeting T cell immunosenescence and inflamm-ageing.

Together with the State Agency for the Higher Council for Scientific Research (CSIC, Consejo Superior de Investigaciones Científicas), Navarrabiomed represents the spanish research for the ISOLDA project. 

David Escors Murugarren leads his team with the participation of Grazyna Kochan and Ana Bocanegra for their extensive knowledge of T-cells and oncoinmunology.